The `Golden Cookie Jar'

As an American epidemiologist working in France, I have a unique perspective on the Robert Gallo-Luc Montagnier controversy, diametrically opposed to that expressed by Edward Ahrens (The Scientist, April 13, 1992, page 3). There is an apparent evolution in many professions toward the belief that professionals are chosen, existing within a supercivilization of their peers, not capable of being understood, much less judged, by society as a whole. Ahrens seems to dismiss much of the Gallo affair

Written byClayton Vernon
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

There is an apparent evolution in many professions toward the belief that professionals are chosen, existing within a supercivilization of their peers, not capable of being understood, much less judged, by society as a whole. Ahrens seems to dismiss much of the Gallo affair as merely a lack of "spin control" by the scientific community.

One suspects that, to Ahrens, it matters not whether the "golden cookie jar" belongs to another scientist, as with Montagnier's virus, or to society as a whole, as with the Stanford University indirect-costs fiasco. Rather, when a scientist is caught with his hand in such a cookie jar, he is now to claim a form of limited immunity, due to his all- around good-guy, noble-guy status.

I am curious as to whether Ahrens would extend the same consideration to those homeless on the Upper East Side of New York, who might wish to steal a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies